Jailendra Singh
Stock Analyst at Truist Financial
(0.23)
# 4,608
Out of 5,073 analysts
788
Total ratings
44.1%
Success rate
-4.9%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASTH Astrana Health | Reiterated: Buy | n/a | $37.35 | - | 31 | Sep 29, 2026 | |
| AGL agilon health | Reiterated: Hold | n/a | $90.99 | - | 36 | Sep 28, 2026 | |
| IQV IQVIA Holdings | Reiterated: Buy | $300 → $329 | $276.63 | +18.93% | 48 | Sep 28, 2026 | |
| MDLN Medline | Reiterated: Buy | n/a | $35.31 | - | 9 | Sep 22, 2026 | |
| ICLR ICON Public Limited Company | Reiterated: Buy | n/a | $185.25 | - | 37 | Sep 17, 2026 | |
| MEDP Medpace Holdings | Reiterated: Hold | n/a | $662.48 | - | 20 | Sep 17, 2026 | |
| WAY Waystar Holding | Reiterated: Buy | n/a | $28.84 | - | 18 | Sep 16, 2026 | |
| HIMS Hims & Hers Health | Reiterated: Hold | $32 | $29.21 | +9.55% | 62 | Sep 11, 2026 | |
| FTRE Fortrea Holdings | Reiterated: Buy | n/a | $24.06 | - | 15 | Sep 3, 2026 | |
| PHR Phreesia | Reiterated: Hold | n/a | $12.26 | - | 27 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $6.30 | - | 65 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $320.55 | - | 38 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.57 | - | 42 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 | $13.97 | -14.10% | 38 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 | $33.58 | -28.53% | 30 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $28.44 | +26.58% | 47 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $22.47 | +46.86% | 39 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 → $6 | $4.83 | +24.22% | 53 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $112 | $112.00 | - | 25 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $39.09 | +7.44% | 1 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.03 | - | 2 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $12.06 | - | 1 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $116 | $194.28 | -40.29% | 2 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.79 | n/a | 3 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.06 | n/a | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.83 | n/a | 1 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $70.24 | n/a | 1 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $304.37 | n/a | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $434.13 | n/a | 1 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $43.00 | n/a | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.02 | n/a | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $425.42 | n/a | 1 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $12.99 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.5444 | n/a | 1 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1,270.75 | n/a | 1 | Jul 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $459.40 | n/a | 1 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 → $22 | $41.04 | n/a | 2 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $610 | $417.00 | n/a | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $31 → $16 | $0.5728 | n/a | 19 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $42 → $43 | $0.2188 | n/a | 12 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 → $24 | $1.15 | n/a | 3 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $4 | $0.34 | n/a | 9 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 → $62 | $257.46 | n/a | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $9 → $3.5 | $4.78 | n/a | 4 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 → $180 | $340.43 | n/a | 14 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $230 → $333 | $1,015.50 | n/a | 12 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $21 | $33.45 | n/a | 4 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $178.82 | n/a | 1 | Feb 26, 2020 |
Astrana Health
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $37.35
Upside: -
agilon health
Sep 28, 2026
Reiterated: Hold
Price Target: n/a
Current: $90.99
Upside: -
IQVIA Holdings
Sep 28, 2026
Reiterated: Buy
Price Target: $300 → $329
Current: $276.63
Upside: +18.93%
Medline
Sep 22, 2026
Reiterated: Buy
Price Target: n/a
Current: $35.31
Upside: -
ICON Public Limited Company
Sep 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $185.25
Upside: -
Medpace Holdings
Sep 17, 2026
Reiterated: Hold
Price Target: n/a
Current: $662.48
Upside: -
Waystar Holding
Sep 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $28.84
Upside: -
Hims & Hers Health
Sep 11, 2026
Reiterated: Hold
Price Target: $32
Current: $29.21
Upside: +9.55%
Fortrea Holdings
Sep 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $24.06
Upside: -
Phreesia
Sep 3, 2026
Reiterated: Hold
Price Target: n/a
Current: $12.26
Upside: -
Sep 1, 2026
Reiterated: Hold
Price Target: n/a
Current: $6.30
Upside: -
Aug 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $320.55
Upside: -
Aug 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.57
Upside: -
Aug 13, 2026
Reiterated: Hold
Price Target: $12
Current: $13.97
Upside: -14.10%
Aug 13, 2026
Reiterated: Hold
Price Target: $24
Current: $33.58
Upside: -28.53%
Aug 13, 2026
Reiterated: Buy
Price Target: $36
Current: $28.44
Upside: +26.58%
Aug 13, 2026
Reiterated: Buy
Price Target: $33
Current: $22.47
Upside: +46.86%
Aug 12, 2026
Rated: Hold
Price Target: $7 → $6
Current: $4.83
Upside: +24.22%
Aug 11, 2026
Rated: Buy
Price Target: $112
Current: $112.00
Upside: -
Aug 10, 2026
Reiterated: Buy
Price Target: $42
Current: $39.09
Upside: +7.44%
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.03
Upside: -
Jun 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $12.06
Upside: -
Feb 27, 2026
Reiterated: Buy
Price Target: $116
Current: $194.28
Upside: -40.29%
Sep 4, 2025
Reiterated: Buy
Price Target: n/a
Current: $7.79
Upside: n/a
Jul 30, 2025
Reiterated: Hold
Price Target: n/a
Current: $9.06
Upside: n/a
Jul 17, 2025
Reiterated: Buy
Price Target: n/a
Current: $15.83
Upside: n/a
Jul 2, 2025
Reiterated: Buy
Price Target: n/a
Current: $70.24
Upside: n/a
May 5, 2025
Reiterated: Buy
Price Target: n/a
Current: $304.37
Upside: n/a
Apr 21, 2025
Reiterated: Buy
Price Target: n/a
Current: $434.13
Upside: n/a
Jan 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $43.00
Upside: n/a
Nov 19, 2024
Reiterated: Buy
Price Target: n/a
Current: $1.02
Upside: n/a
Oct 3, 2024
Rated: Hold
Price Target: n/a
Current: $425.42
Upside: n/a
Sep 9, 2024
Reiterated: Hold
Price Target: n/a
Current: $12.99
Upside: n/a
Sep 4, 2024
Reiterated: Buy
Price Target: n/a
Current: $0.5444
Upside: n/a
Jul 3, 2024
Reiterated: Buy
Price Target: n/a
Current: $1,270.75
Upside: n/a
Apr 29, 2024
Reiterated: Buy
Price Target: n/a
Current: $459.40
Upside: n/a
Apr 16, 2024
Reiterated: Hold
Price Target: $21 → $22
Current: $41.04
Upside: n/a
Nov 29, 2022
Reiterated: Buy
Price Target: $610
Current: $417.00
Upside: n/a
Mar 3, 2022
Reiterated: Hold
Price Target: $31 → $16
Current: $0.5728
Upside: n/a
Feb 28, 2022
Reiterated: Hold
Price Target: $42 → $43
Current: $0.2188
Upside: n/a
Feb 24, 2022
Reiterated: Hold
Price Target: $30 → $24
Current: $1.15
Upside: n/a
Feb 8, 2022
Downgraded: Hold
Price Target: $14 → $4
Current: $0.34
Upside: n/a
Jan 7, 2022
Reiterated: Hold
Price Target: $50 → $62
Current: $257.46
Upside: n/a
Jan 7, 2022
Downgraded: Sell
Price Target: $9 → $3.5
Current: $4.78
Upside: n/a
Jan 7, 2022
Reiterated: Buy
Price Target: $145 → $180
Current: $340.43
Upside: n/a
Jan 7, 2022
Upgraded: Buy
Price Target: $230 → $333
Current: $1,015.50
Upside: n/a
Nov 11, 2021
Reiterated: Buy
Price Target: $26 → $21
Current: $33.45
Upside: n/a
Feb 26, 2020
Reiterated: Buy
Price Target: $30
Current: $178.82
Upside: n/a